Please refer attached letter on closure of trading window for the quarter ended September 2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Tejnaksh Healthcare Ltd has informed the BSE that the trading window for dealing in its securities will remain closed for Directors, Key Managerial Personnel, designated employees, and other connected persons starting from October 1, 2025. The window will reopen 48 hours after the company's financial results for the quarter and half-year ending September 30, 2025 are made public. This is a routine compliance action taken under SEBI's Prohibition of Insider Trading Regulations, 2015. The letter was signed by Managing Director Dr. Ashish V. Rawandale (DIN: 02005733) on September 24, 2025.
This is a standard regulatory disclosure and not a material event for shareholders. It simply means company insiders are restricted from trading in the stock until after the upcoming Q2 results are announced, which is normal practice ahead of earnings releases.